Corey N. Fishman Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Corey N. Fishman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Corey N. Fishman. Corey N. Fishman is a Director in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and a Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and a COO & CFO in Durata Therapeutics, Inc. ($DRTX) and a President & CEO in Iterum Therapeutics plc ($ITRM).
Address: C/O DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR MORRISTOWN 07960 NJ
Companies in which Corey N. Fishman is an Insider
BIOSPECIFICS TECHNOLOGIES CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Corey N. Fishman: Director
Holdings: 2,018 shares
Latest Transaction: May 04 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Durata Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Corey N. Fishman: COO & CFO
Holdings: 22,441 shares
Latest Transaction: Jul 26 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Iterum Therapeutics plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Corey N. Fishman: President & CEO
Holdings: 407,453 shares
Latest Transaction: Mar 15 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MOMENTA PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Corey N. Fishman: Director
Holdings: 10,090 shares
Current Value: $190,197
Latest Transaction: Jun 21 2019
$MNTA Market Capitalization: $1.29B
$MNTA Previous Close: $18.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Corey N. Fishman
Sentiment: All, BSTCE, DRTX, ITRM, MNTA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15 2021 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Option Exercise | A | 0.00 | 430,000 | 0 | 430,000 | |
| Jan 27 2021 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Sell | S | 1.73 | 85,445 | 147,820 | 322,008 | 407.5 K to 322 K (-20.97 %) |
| Jan 27 2021 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Grant | A | 0.00 | 167,500 | 0 | 407,453 | 240 K to 407.5 K (+69.81 %) |
| May 04 2020 | BSTCE | BIOSPECIFICS TECHN ... | Fishman Corey N. | Director | Option Exercise | A | 55.63 | 6,000 | 333,780 | 6,000 | |
| Apr 15 2020 | BSTCE | BIOSPECIFICS TECHN ... | Fishman Corey N. | Director | Grant | A | 0.00 | 2,018 | 0 | 2,018 | 0 to 2 K |
| Jun 21 2019 | MNTA | MOMENTA PHARMACEUT ... | Fishman Corey N. | Director | Option Exercise | M | 0.00 | 4,356 | 0 | 0 | |
| Jun 21 2019 | MNTA | MOMENTA PHARMACEUT ... | Fishman Corey N. | Director | Option Exercise | A | 12.64 | 25,000 | 316,000 | 25,000 |